Monitor the next 10-Q or 10-K for any unexpected adjustments or changes in accounting policies under PwC. The clean transition and Big 4-to-Big 4 switch suggest low risk, but the stock's historical poor performance on prior filings warrants caution.
Price Chart
Executive Summary
Coherus Oncology dismissed Ernst & Young as its independent auditor and appointed PricewaterhouseCoopers, effective June 12, 2026. The filing states no disagreements with EY on accounting principles or audit scope, and a previously reported material weakness in internal controls over inventory reconciliations has been remediated. This is a routine auditor change between Big 4 firms with no adverse opinions or reportable events, carrying limited immediate stock impact.
Key Facts
- Ernst & Young (EY) was dismissed as independent auditor effective June 12, 2026.
- PricewaterhouseCoopers (PwC) was selected as the new independent auditor for fiscal year 2026, subject to standard client acceptance procedures.
- No disagreements (as defined in Item 304(a)(1)(iv)) occurred between Coherus and EY during fiscal years 2024, 2025, or the subsequent interim period.
- A material weakness in internal control over financial reporting related to inventory account reconciliations was reported in the 2024 10-K but was remediated as of the 2025 10-K.
- EY's letter to the SEC agrees with the statements in the 8-K's first four paragraphs.
Financial Impact
No direct financial impact; auditor change is administrative with no restatement or financial adjustments disclosed.
Risk Factors
- Potential undisclosed disagreements or control issues not captured in the filing.
- Market may interpret any auditor change negatively despite no adverse findings.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001104659-26-074090 |
| Document: chrs-20260612xex16d1.htm | 0001104659-26-074090 |
| Document: 0001104659-26-074090-index-headers.html | 0001104659-26-074090 |
| Document: 0001104659-26-074090-index.html | 0001104659-26-074090 |
| Document: 0001104659-26-074090.txt | 0001104659-26-074090 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 17, 2026 6w ago | Press Release | $1.34 $1.29 | ▼ −4.10% | ▼ −3.11% | $1.16 (−13.43%) |
Jul 22, 2026 10w ago | Press Release | $1.43 $1.33 | ▼ −6.99% | ▼ −9.89% | $1.16 (−18.88%) |
Jun 15, 2026 15w ago | 8-K | $1.38 $1.45 | ▲ +5.07% | ▲ +4.87% | $1.16 (−15.94%) |
Jun 12, 2026 16w ago | Institutional Cluster | $1.40 $1.54 | ▼ −10.00% | ▼ −8.22% | $1.16 (+17.14%) |
May 28, 2026 18w ago | DEFA14A | $1.65 $1.50 | ▼ −9.09% | ▼ −5.95% | $1.16 (−29.70%) |
May 11, 2026 20w ago | Press Release | $1.71 $1.36 | ▼ −20.47% | ▼ −18.74% | $1.16 (−32.16%) |
May 5, 2026 21w ago | DEFA14A | $1.75 $1.47 | ▼ −16.00% | ▼ −18.78% | $1.16 (−33.71%) |
May 4, 2026 21w ago | Press Release | $1.73 $1.57 | ▼ −9.25% | ▼ −14.89% | $1.16 (−32.95%) |
Mar 9, 2026 29w ago | Press Release | $1.95 $1.70 | ▼ −12.82% | ▼ −12.67% | $1.16 (−40.51%) |
Mar 2, 2026 30w ago | Press Release | $1.65 $1.60 | ▼ −3.03% | ▲ +4.91% | $1.16 (−29.70%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access